跳至主要内容
临床试验/IRCT20200415047080N2
IRCT20200415047080N2已完成2 期

Evaluation of the effectiveness of thiamine-ascorbic acid-methylprednisolone (TAM) cocktail in the treatment of critically ill patients with coronavirus pneumonia (Covid-19) in a clinical trial study

Tehran University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Informed written consent is obtained before the start of the study process.
  • patient understands and agrees with planned study methods.
  • Agree on sampling the oropharyngeal polymerase chain reaction and venous blood samples according to the protocol.
  • A non-pregnant woman and man is 18 years of age or older when entering the program.
  • Positive Covid 19 polymerase chain reaction test with at least one of the following: radio-graphic changes or with clinical signs requiring mechanical ventilation and air oxygen saturation level less than or equal to 94% in room air.
  • Women of childbearing age should have at least one contraceptive method during the study

排除标准

  • Allergic reaction to Hydrocortisone, Ascorbic acid or thiamine
  • Hospitalization less than 72 hours
  • Active kidney stone
  • The patient participates in another clinical trial at the same time

研究者

相似试验

Evaluation of the effectiveness of TAC cocktail in... | 临床试验